Navigation Links
Concentric Named Professional Agency of Record for Discovery Labs' SURFAXIN(R)
Date:9/3/2008

NEW YORK, Sept. 3 /PRNewswire/ -- Concentric Pharma Advertising, one of the fastest growing marketing agencies in the healthcare field, has been named agency of record by Discovery Labs for SURFAXIN(R) (lucinactant), an investigational drug being reviewed by the Food and Drug Administration for the treatment of respiratory distress syndrome (RDS) in newborns.

"We selected Concentric for this assignment because the company's strategic insight and creative vision best captured the essence of the SURFAXIN brand," said John Wilson, vice president of sales and marketing at Discovery, adding that the agency's in-depth knowledge of neonatology and acute RDS in premature infants also played a significant part in the decision.

The full-service U.S. assignment will include a wide range of activities, including corporate and product branding, positioning, and the creation of support materials geared to neonatologists, neonatal intensive care unit (NICU) nurses, respiratory therapists, hospital pharmacists, and, potentially, parents of newborns. The agency's account team will be led by Ed Mutch, account supervisor. Blake Benner, director of marketing at Discovery Labs, will manage the account on the client side.

Discovery Labs, headquartered in Warrington, Pa., is a biotechnology company developing novel surfactant replacement therapies (SRTs) with potential for application across the continuum of respiratory diseases, initially focusing on RDS in premature infants.

About Concentric

Concentric Pharma Advertising, an independent healthcare advertising and marketing firm established in 2002, is one of the fastest growing agencies in the healthcare field, enjoying double-digit revenue growth for the fourth year in a row. In the past year alone, the agency won 10 new assignments, launched a new division, expanded its senior management team, and won several awards in prestigious U.S. and global ad competitions.

Concentric offers a wide range of fully integrated marketing services, including professional and DTC advertising, corporate and product branding, sales force education, sales promotion, strategic and tactical planning, digital media, managed markets planning, formulary access programs, relationship marketing, and a full range of patient and consumer education programs. Clients include Alcon Labs, Bayer HealthCare, Cobalt Laboratories, Coria Laboratories, Discovery Labs, Mitsubishi Pharma USA, Neuromed, Pfizer and Wyeth.

Concentric is located at 71 West 23rd St, 9th floor, New York, NY 10010, but will soon be moving into spacious new quarters in lower Manhattan. To learn more, visit http://www.concentric-rx.com , call 212-633-9700, or email info@concentric-rx.com.

CONTACT: Julie Laitin (212) 286-2424 Cynthia Amorese (908) 665-8072

Email: jlaitin@julielaitin.com Email: camorese@comcast.net


'/>"/>
SOURCE Concentric Pharma Advertising
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
2. Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
3. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
4. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
5. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
6. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
7. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
8. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
9. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
10. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
11. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2019)... ... November 08, 2019 , ... ... technology for use in pathology research, today announced the results of analyses ... patients enrolled in the phase 3 selonsertib studies (STELLAR). Strong correlations were ...
(Date:11/5/2019)... ... November 05, 2019 , ... Ole, a German Shepherd, was demonstrating signs of osteoarthritis in April ... Though his energy level and his willingness to play were normal, it was clear that ... of VCA Emergency Animal Hospital and Referral Center in San Diego, California. ...
(Date:10/30/2019)... ... October 30, 2019 , ... Western University of ... innovation and technology play in educating the next generation of health care providers. ... and presentations by WesternU administrators and representatives of companies working with the University ...
(Date:10/22/2019)... , ... October 22, 2019 , ... nQ Medical, Inc. ... School’s 2019 Most Fundable Companies List which was announced at a showcase event yesterday ... million in annual revenue, strong business plans, and impressive near-term growth projections to be ...
Breaking Biology Technology:
(Date:11/12/2019)... ... November 12, 2019 , ... Atlantic Ultraviolet Corporation (AUV), the ... distributors voted their patented automatic and manual wipers the #1 best feature of ... frequent maintenance task required of an ultraviolet water purifier is quartz sleeve cleaning. ...
(Date:11/9/2019)... Idaho (PRWEB) , ... November 08, 2019 , ... SiteSeer ... GPK Acquisitions as a new client and user of SiteSeer. The boutique real ... acres across the U.S. will use SiteSeer to supplement its own analysis of markets. ...
(Date:11/7/2019)... ... ... R3 Stem Cell is now offering its comprehensive Online Stem Cell Training ... during checkout is FIFTYOFF and applies to both the one month access and the ... over 12,000 successful stem cell procedures performed nationwide. A couple years ago, R3 began ...
Breaking Biology News(10 mins):